Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 14 Dec 2023 for XORTX Therapeutics Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
James Neville Fairbairn: trading record in brief
This profile gathers the share dealings of James Neville Fairbairn in XORTX Therapeutics Inc. The record holds 4 filings, for trades running from 29 June 2023 to 10 November 2023.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 14 December 2023 with a transaction in XORTX Therapeutics Inc. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Companies and markets linked to James Neville Fairbairn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
13,408 sharesCommon SharesTSXSEDI:4225411
Common SharesTSXSEDI:4225406
Common SharesTSXSEDI:4225407
42,160 sharesCommon SharesTSXSEDI:4225412
4 of 4 declarations
